Canada’s Drug Agency seeks 4 members for our Appropriate Use Advisory Committee (AUAC). AUAC is a forum to share information, enhance capacity, support collaboration, and provide advice to address the appropriate use of medications across Canada. Apply by March 30.
Canada’s Drug Agency seeks 2 expert members for our Formulary Management Expert Committee (FMEC). FMEC issues drug reimbursement recommendations to the participating public drug programs and cancer agencies (except Quebec). FMEC also trials innovative approaches to health technology assessment. Apply by March 30.
Canada’s Drug Agency seeks up to 1 expert member for our pan-Canadian Oncology Drug Review Expert Review Committee (pERC). pERC issues reimbursement recommendations for oncology drugs to the participating public drug programs and cancer agencies (except Quebec). Apply by March 30.
Bridge Medical Communications are hosting the upcoming EmpowerHER Women’s Health Summit: Oncology Edition, focused on gastrointestinal, breast, lung, and gynecologic oncology.
A.C.T.I.O.N in Myeloma is a virtual, accredited program for pharmacists and nurses, exploring the practical use of anti-BCMA therapies for relapsed/refractory myeloma.
Members are invited to join an exciting international pharmacy debate: "Pharmacogenomics is Over-Rated” presented in collaboration with the Canadian Association of
